Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14732624 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-Oxidant Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Vitamin E, Vitamin C, and Alpha-lipoic Acid;   Drug: Coenzyme Q;   Drug: Placebo capsules;   Drug: Placebo wafers

Indicates status has not been verified in more than two years